• UA System Patent Policy
• UAB Conflicts of Interest Policy
• UAB Conflicts of Commitment Policy
The UAB-Wyeth Licensing Agreement Has Long-Term GoalsIn December 1999, The UAB Research Foundation (UABRF) and Wyeth signed an exclusive license agreement for the development of vaccines against certain viral diseases using vesicular stomatitis virus (VSV) as a vector for vaccine delivery. This license agreement granted Wyeth exclusive rights to a large body of technology that had been created at the University of Alabama at Birmingham (UAB).
Over the past nine years, Wyeth has been developing this technology in accordance with the terms of its exclusive license agreement. UABRF and Wyeth also have cooperated to ensure that the associated intellectual property is protected.